Comparative Evaluation of Chiglitazar and Sitagliptin on the Levels of Retinol-Binding Protein 4 and Its Correlation With Insulin Resistance in Patients With Type 2 Diabetes

AIMS: We evaluated the efficacy and significant changes in the levels of retinol-binding protein 4 (RBP-4) and insulin resistance in patients with type 2 diabetes mellitus (T2DM) treated with chiglitazar versus sitagliptin. METHODS: Eighty-one T2DM patients with haemoglobin A1c (HbA1c) level of 7.5%...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yunting, Wang, Huiying, Wang, Yuming, Xu, Xiaohua, Li, Fengfei, Zhou, Junming, Shan, Ting, Huang, Rong, Cai, Tingting, Liu, Xiaomei, Su, Xiaofei, Li, Huiqin, Ma, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081976/
https://www.ncbi.nlm.nih.gov/pubmed/35547000
http://dx.doi.org/10.3389/fendo.2022.801271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081976/
https://www.ncbi.nlm.nih.gov/pubmed/35547000
http://dx.doi.org/10.3389/fendo.2022.801271

Ejemplares similares